Streetwise Medical Devices Articles
SmileDirectClub Granted Patent for Mobile Oral Care Bus to Serve Remote Regions in the US & UK
Source: Streetwise Reports (10/5/21)
SmileDirectClub Inc. shares traded 15% higher after the company reported that the U.S. Patent & Trademark Office has allowed its new patent for the firm's mobile SmileBus concept whereby its SmileShop on wheels is mobilized to expand access to convenient, affordable oral care in remote areas across the U.S. and the U.K.
More >
Telemedicine Tech Firm Poised to Generate $11 Million of Revenue
Source: Streetwise Reports (9/24/21)
Reliq Health Technologies signs contracts with three new clients for its proprietary remote healthcare delivery and care tracking platform, which has particularly significant implications during the era of the COVID-19 pandemic.
More >
Medical Device Company's Improved Fundamentals Offer Multiple Expansion Potential
Source: Streetwise Reports (9/7/21)
ROTH Capital Partners LLC commented in a research report that it is maintaining its "Buy" rating and raising its FY/22 revenue estimates for Dynatronics Corp. to $41 million after the firm pre-announced Q4/21 revenue figures that exceeded prior estimates.
More >
Third Implantation of Device Firm's Total Artificial Heart That 'Could Save Many Patients Who May Die'
Source: Streetwise Reports (8/30/21)
An H.C. Wainwright & Co. report noted that Carmat's Aeson implant "could save many patients who may die, due to [a] shortage of donor hearts, while waiting for a heart transplant."
More >
Dermatological Device Company to Acquire Laser System Firm
Source: Streetwise Reports (8/24/21)
An H.C. Wainwright report noted that "this deal is an opportunity for STRATA Skin Sciences to substantially increase its long-term, recurring revenue base."
More >
Diagnostics Firm Readies for Pivotal FDA Study of Device That Detects Bacterial Lung Infections
Source: Streetwise Reports (8/18/21)
Promising early results and a new line of equity support Avisa Diagnostic’s drive for IDE approval of its rapid-response breath test for pneumonia, TB, CF, and other lung ailments.
More >
STAAR Shares Burst Higher after Firm Posts 77% Increase in Q2 Net Sales and Raises FY Outlook
Source: Streetwise Reports (8/6/21)
Shares of STAAR Surgical Co. traded 20% higher after the company reported Q2/21 financial results highlighting a 93% YoY increase in net sales of its Implantable Collamer® Lenses.
More >
Coverage Initiated on Company with a 'Genuine Physiological Heart Replacement Therapy'
Source: Streetwise Reports (7/21/21)
The investment thesis for the device company Carmat, whose therapy "allows patients to live with almost normal quality of life," is presented in an H.C. Wainwright & Co. report.
More >
Biopharma Partners with NIH to Advance Women's Hormone-Free Contraceptive
Source: Streetwise Reports (7/21/21)
A Roth Capital Partners report calls this a "very cost-effective and strategic move" for Daré Bioscience.
More >
Zynex Shares Rise as Firm Notches Significant Q2 Order Growth and Raises EBITDA Outlook
Source: Streetwise Reports (7/16/21)
Zynex Inc. shares traded 10% higher after the electrotherapy medical device maker reported a 247% YoY growth in orders during Q2/21 and raised the range for its EBITDA estimates in the quarter by $1.2 million.
More >
Pulse Bio Shares Beat Higher on Launch of CellFX NPS System in Canada
Source: Streetwise Reports (7/1/21)
Pulse Biosciences shares traded 27% higher after the company announced it secured a $50 million private placement one day after it reported the first CellFX® procedure using its proprietary Nano-Pulse Stimulation technology had been performed in Canada.
More >
Second Sight Shares Shine Brightly After Firm Posts Orion Study Results
Source: Streetwise Reports (5/12/21)
Second Sight Medical Products Inc. shares traded 25% higher after the company reported the results from a two-year study of its Orion Visual Cortical Prosthesis System.
More >
AbbVie's Allergan Aesthetics to Acquire Soliton for $550 Million
Source: Streetwise Reports (5/10/21)
Soliton Inc. shares traded 25% higher after the company reported it had agreed to be acquired by AbbVie Inc.'s Allergan Aesthetics for $22.60 per share in an all cash transaction.
More >
CryoLife Shares Trade 18% Higher on Q1 Financial Results
Source: Streetwise Reports (4/30/21)
Shares of CryoLife Inc. set a new 52-week high intraday price after the company reported that total revenues in Q1/21 increased by 7% YoY to $71.1 million.
More >
Nano-X Imaging Receives Go Ahead from FDA for Single Source Digital X-Ray
Source: Streetwise Reports (4/5/21)
Shares of Nano-X Imaging Ltd. traded 17% higher after the company reported that the FDA has granted 510(k) approval for its single source ARC digital x-ray.
More >
Shockwave Medical Reports 100% Increase in Preliminary Q1 Revenue
Source: Streetwise Reports (3/30/21)
Shockwave Medical Inc. shares gained 19% after the company announced that sales of its recently launched C2 Coronary IVL System are growing steadily and are driving revenue growth.
More >
Investors Seeing Green as FDA Approves Second Sight Medical's Argus 2s Retinal Prosthesis System
Source: Streetwise Reports (3/5/21)
Second Sight Medical Products shares trade more than 400% higher after the company reported that the FDA granted approval for its Argus 2s Retinal Prosthesis System designed to deliver useful artificial vision to blind individuals diagnosed with retinitis pigmentosa.
More >
FDA Grants Expanded Use in General Surgery for Asensus Surgical's Robotic Laparoscopic Platform
Source: Streetwise Reports (3/3/21)
Asensus Surgical shares traded 16.5% higher after the company reported it received clearance from the U.S. Food & Drug Administration for its Senhance© Surgical System for use in general surgical procedures.
More >
Virtual HealthCare Tech Firm Contracts to Provide Patient Care Platform to US Nephrology Clinic
Source: Streetwise Reports (2/26/21)
Reliq Health Technologies reported it signed a new agreement with a Texas-based nephrology clinic to provide its iUGO Care platform to patients with chronic kidney disease.
More >
Owens & Minor Shares Soar 36% After Firm Reports Record Q4 Earnings and Positive 2021 Outlook
Source: Streetwise Reports (2/24/21)
Shares of Owens & Minor Inc. soared to a new 52-week high after the company reported Q4/20 and FY/20 financial results that were boosted by a 58% gain in global products revenue and increases in elective medical procedures.
More >
Digital Therapeutics Leader DarioHealth Makes a Critical Acquisition
Source: Matt Badiali for Streetwise Reports (2/17/21)
Independent financial analyst Matt Badiali discusses DarioHealth's latest acquisition and what it means for the company's growth.
More >
PAVmed Shares Increase 28% after First US Patient Treated with CarpX Device for Carpal Tunnel Syndrome
Source: Streetwise Reports (2/16/21)
PAVmed Inc. shares reached a new 52-week high after the company reported that the first patient in the U.S. was successfully treated with its CarpX® Device, a minimally invasive carpal tunnel release surgical instrument.
More >
Align Technology Shares Grind 12.5% Higher after Firm Posts Record Q4 Revenue of $834.5 Million
Source: Streetwise Reports (2/4/21)
Align Technology shares set a new 52-week high after the company announced financial results that included record FY/20 total revenues of $2.5 billion.
More >
Abiomed Shares Gain 8% After Firm Announces Record Q3 Revenue of $232 Million
Source: Streetwise Reports (1/28/21)
Shares of cardiac medical device maker Abiomed Inc. traded higher after the company reported record revenue for Q3/21 despite the impact from COVID-19.
More >
Avinger Shares Rise 40% on Launch of Image-Guided Device to Diagnose and Treat PAD
Source: Streetwise Reports (1/15/21)
Shares of Avinger Inc. reached a new 52-week high after the company reported it initiated a full commercial launch of its Tigereyeâ„¢ Image-Guided CTO Crossing Catheter system for diagnosing and treating peripheral artery disease.
More >